uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Is erythromycin therapy teratogenic in humans?
Uppsala University, Medicinska vetenskapsområdet, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
2005 (English)In: Reprod Toxicol, ISSN 0890-6238, Vol. 20, no 2, 209-14 p.Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2005. Vol. 20, no 2, 209-14 p.
Keyword [en]
Adult, Confidence Intervals, Erythromycin/*therapeutic use/*toxicity, Female, Heart Defects; Congenital/*epidemiology/*etiology, Humans, Infant; Newborn, Interviews, Odds Ratio, Pregnancy, Pyloric Stenosis/epidemiology/etiology, Registries, Retrospective Studies, Risk Factors, Sweden/epidemiology, Teratogens/*toxicity
URN: urn:nbn:se:uu:diva-26188PubMedID: 15907655OAI: oai:DiVA.org:uu-26188DiVA: diva2:53962
Available from: 2007-02-15 Created: 2007-02-15 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Danielsson, Bengt R
By organisation
Department of Pharmaceutical Biosciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 172 hits
ReferencesLink to record
Permanent link

Direct link